Topical versus Intrastromal Voriconazole for treatment of Recalcitrant fungal Corneal Ulcer: A Randomised Controlled Trial

doi:10.5281/zenodo.13267797

International Journal of Medical and Pharmaceutical Research

2024, Volume-5, Issue-4 doi: 10.5281/zenodo.13267797

Original Research Article

Topical versus Intrastromal Voriconazole for treatment of Recalcitrant fungal Corneal Ulcer: A Randomised Controlled Trial

Rani Pooja, Dokania Ashutosh

DOI : 10.5281/zenodo.13267797

Published

Aug. 8, 2024

Abstract

Purpose: To compare the safety and efficacy of intrastromalvoriconazole injection with topical voriconazole in management of fungal corneal ulcer not responding to conventional therapy.Patients and methods: A comparative and randomized study performed on patients with resistant fungal keratitis.Half of the patients (Group A) were given intrastromal injection in the dose of 0.1 ml (50 microgram/0.1ml) in each injection , Half of the patients (Group B) were given topical voriconazole eye drops (1%) once hourly. Healing of keratitis was considered as primary outcome measure.Results: Each group included 35 eyes with resistant fungal keratitis. Complete healing of fungal keratitis was higher in group A (88.6%) than in group B (31.4%) and the difference was statistically significant (P0.05).Conclusion: Voriconazole topically might be effective for treatment of resistant fungal keratitis. Adding intrastromal injection to topical drops could significantly raise the healing rate and hasten the resolution period without significant complications related to injection.

Recommended Articles

Volume-5, Issue-4

Downloads

Download PDF pdf

Download XML

Citations

467 Views

42 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.